PRTN3 and rheumatoid arthritis: Interestingly, this is particularly evident in female patients, suggesting that sex-specific factors may contribute to the pathogenic role of ACPA in the induction of CV disease risk in RA and, in consequence, a more careful CV screening particularly in ACPA-positive females with RA.